¿Qué hacer? ¿Cómo actuar respetando la dignidad del paciente? | 27 MAY 13

Atención hospitalaria del paciente moribundo

El paquete de medidas AMBER es una herramienta diseñada en el Reino Unido para facilitar este proceso, al promover la comunicación, el planeamiento de la atención médica y el trabajo en equipo junto con el tratamiento activo.
Autor/a: Dres. Sleeman KE, Collis E. BMJ 2013;346:f2174, abril 2013
INDICE:  1. Artículo | 2. Referencias

1. Linklater GT. Educational needs of foundation doctors caring for dying patients. J R CollPhysicians Edinb 2010;40:13-8.
2. Department of Health. End of life care strategy: promoting high quality care for all adults at the end of life. DH, 2008.
3. NHS Scotland. Living and dying well, a national action plan for palliative and end of life care in Scotland. NHS Scotland, 2008.
4. General Medical Council. Treatment and care towards the end of life: good practice in decision making. GMC, 2010.
5. Mayor S. Care of dying patients and safety dominate report on NHS complaints. BMJ 2007;334:278.
6. Guy’s and St Thomas’ NHS Foundation Trust. AMBER care bundle. www. ambercarebundle.org/Resources/Resources.aspx.
7. NHS UK. National end of life care programme. Transforming end of life care in acute hospitals: the route to success. “How to” guide. NHS UK, 2012.
8. National Care of the Dying Audit—Hospitals (NCDAH): round 3. Marie Curie Palliative Care Institute Liverpool. 2012.
9. Marie Curie Palliative Care Institute. The Liverpool care pathway for the dying patient (LCP) core documentation. MCPI, 2009.
10. National Institute for Health and Clinical Excellence. Quality standard for end of life care for adults. NICE, 2011.
11. McCartney M. The assault on the Liverpool care pathway. BMJ 2012;345:e7316.
12. Royal College of Physicians and British Society of Gastroenterology. Oral feeding difficulties and dilemmas. A guide to practical care, particularly towards the end of life. Report of a working party. RCP, 2010.
13. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006;31:58-69.
14. Department of Health. First National VOICES survey of bereaved people: key findings report. DH, 2012.
15. Jennings A, Davies A, Higgins J, Gibbs J, Broadley K. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002:57:939-44.
16.  Kamal AH, Maguire JM, Wheeler JL, Currow DC, Abernethy AP. Dyspnea review for the palliative care professional: treatment goals and therapeutic options. J Palliat Med 2012;15:106-14.
17. Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev 2010;1:CD007354.
18. Association for Palliative Medicine. APM position on the double effect (DE). APM, 2009.



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022